SnapShot: Brain-targeting anti-obesity medications

Jonas Petersen; Valdemar Brimnes Ingemann Johansen; Christoffer Clemmensen

doi:10.1016/j.cmet.2025.02.006

SnapShot: Brain-targeting anti-obesity medications

Jonas Petersen, Valdemar Brimnes Ingemann Johansen, Christoffer Clemmensen^*

^*Corresponding author af dette arbejde

Clemmensen Group

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Abstract

Advances in the understanding of homeostatic regulation of body weight and the neurobiology of appetite, combined with innovations in medicinal chemistry, have paved the way for safe and effective weight loss medications. Long-acting GLP-1 receptor agonists have revolutionized obesity treatment, and, together with emerging GLP-1-based multi-agonists and combination therapies, offer significant potential to combat cardiometabolic diseases and a range of other chronic health challenges. To view this SnapShot, open or download the PDF.

Originalsprog	Engelsk
Tidsskrift	Cell Metabolism
Vol/bind	37
Udgave nummer	3
Sider (fra-til)	790-790.e1
Antal sider	2
ISSN	1550-4131
DOI	https://doi.org/10.1016/j.cmet.2025.02.006
Status	Udgivet - 2025

Bibliografisk note

Publisher Copyright:
© 2025 Elsevier Inc.

Adgang til dokumentet

10.1016/j.cmet.2025.02.006

Citationsformater

@article{3c654b9ba6064b108aed70bd5a0a4712,

title = "SnapShot: Brain-targeting anti-obesity medications",

abstract = "Advances in the understanding of homeostatic regulation of body weight and the neurobiology of appetite, combined with innovations in medicinal chemistry, have paved the way for safe and effective weight loss medications. Long-acting GLP-1 receptor agonists have revolutionized obesity treatment, and, together with emerging GLP-1-based multi-agonists and combination therapies, offer significant potential to combat cardiometabolic diseases and a range of other chronic health challenges. To view this SnapShot, open or download the PDF.",

author = "Jonas Petersen and {Ingemann Johansen}, {Valdemar Brimnes} and Christoffer Clemmensen",

note = "Publisher Copyright: {\textcopyright} 2025 Elsevier Inc.",

year = "2025",

doi = "10.1016/j.cmet.2025.02.006",

language = "English",

volume = "37",

pages = "790--790.e1",

journal = "Cell Metabolism",

issn = "1550-4131",

publisher = "Cell Press",

number = "3",

}

TY - JOUR

T1 - SnapShot

T2 - Brain-targeting anti-obesity medications

AU - Petersen, Jonas

AU - Ingemann Johansen, Valdemar Brimnes

AU - Clemmensen, Christoffer

PY - 2025

Y1 - 2025

N2 - Advances in the understanding of homeostatic regulation of body weight and the neurobiology of appetite, combined with innovations in medicinal chemistry, have paved the way for safe and effective weight loss medications. Long-acting GLP-1 receptor agonists have revolutionized obesity treatment, and, together with emerging GLP-1-based multi-agonists and combination therapies, offer significant potential to combat cardiometabolic diseases and a range of other chronic health challenges. To view this SnapShot, open or download the PDF.

AB - Advances in the understanding of homeostatic regulation of body weight and the neurobiology of appetite, combined with innovations in medicinal chemistry, have paved the way for safe and effective weight loss medications. Long-acting GLP-1 receptor agonists have revolutionized obesity treatment, and, together with emerging GLP-1-based multi-agonists and combination therapies, offer significant potential to combat cardiometabolic diseases and a range of other chronic health challenges. To view this SnapShot, open or download the PDF.

U2 - 10.1016/j.cmet.2025.02.006

DO - 10.1016/j.cmet.2025.02.006

M3 - Comment/debate

C2 - 40043693

AN - SCOPUS:85218910438

SN - 1550-4131

VL - 37

SP - 790-790.e1

JO - Cell Metabolism

JF - Cell Metabolism

IS - 3

ER -